Acadia Healthcare Company, Inc.(ACHC)Earnings, Financials & Key RatiosAcadia Healthcare Company, Inc. (ACHC) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to generate consistent free cash flow, combined with a debt-to-equity ratio of 1.23 and a massive $1.2 billion net loss in 2025Q4, suggests significant underlying financial instability.
Acadia Healthcare Company, Inc. (ACHC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Acadia Healthcare Company, Inc. (ACHC) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 29, 2026 | $0.37vs $0.28+32.1% | $829Mvs $824M+0.6% |
| Q1 2026 | Feb 25, 2026 | $0.07vs $0.03+133.3% | $821Mvs $800M+2.7% |
| Q4 2025 | Nov 5, 2025 | $0.72vs $0.68+5.9% | $852Mvs $848M+0.4% |
| Q3 2025 | Aug 5, 2025 | $0.83vs $0.71+16.9% | $869Mvs $875M-0.7% |
Recent stock market news and headlines for Acadia Healthcare Company, Inc. (ACHC)
The Zacks Medical-Hospital industry is adapting as care shifts beyond inpatient settings, demand rises and earnings outlook improves. THC, UHS, ACHC and CYH stand out.
ACHC is shifting from expansion to returns, raising EBITDA guidance as mature facilities and rising demand support its turnaround strategy.
Key metrics vs top competitors for Acadia Healthcare Company, Inc. (ACHC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $31.25 | $2.88B | -2.57 | 5.04% | -33.29% | -41.37% | — | |
| $150.58 | $9.42B | 6.52 | 9.71% | 8.56% | 20.65% | — | |
| $16.51 | $2.05B | 13.99 | 5.12% | 2.42% | 6.57% | — | |
| $16.60 | $2.17B | -27.21 | 6.24% | -2.28% | -2.15% | — | |
| $15.82 | $3.76B | -14.25 | 4.77% | -6.58% | -23450.43% | — | |
| $164.82 | $9.63B | 28.22 | 18.72% | 6.89% | 16.61% | — |
Acadia Healthcare Company, Inc. (ACHC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Acadia Healthcare Company, Inc. (ACHC) SEC filings — annual & quarterly reports (10-K, 10-Q)
Apr 29, 2026·SEC
Apr 23, 2026·SEC
Mar 12, 2026·SEC
Get notified when ACHC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Acadia Healthcare Company, Inc. (ACHC) stock FAQ — growth, dividends, profitability & financials explained
Acadia Healthcare Company, Inc. (ACHC) reported $3.37B in revenue for fiscal year 2025. This represents a 1423% increase from $221.4M in 2011.
Acadia Healthcare Company, Inc. (ACHC) grew revenue by 5.0% over the past year. This is steady growth.
Acadia Healthcare Company, Inc. (ACHC) reported a net loss of $1.11B for fiscal year 2025.
Acadia Healthcare Company, Inc. (ACHC) has a return on equity (ROE) of -41.4%. Negative ROE indicates the company is unprofitable.
Acadia Healthcare Company, Inc. (ACHC) had negative free cash flow of $215.2M in fiscal year 2025, likely due to heavy capital investments.
